Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / BIOVF - Selecta Bio and Sobi ink licensing deal for SEL-212


BIOVF - Selecta Bio and Sobi ink licensing deal for SEL-212

  • Selecta Biosciences (NASDAQ:SELB) and Swedish Orphan Biovitrum AB (OTCPK:BIOVF) have entered into a strategic licensing agreement for the product candidate SEL-212, designed to durably control serum uric acid, reduce immunogenicity, and allow for repeated monthly dosing for the treatment of chronic refractory gout.
  • More news on: Selecta Biosciences, Inc., Swedish Orphan Biovitrum AB (publ), Healthcare stocks news,
  • Read more ...
Stock Information

Company Name: Swedish Orphan Biovit Ord
Stock Symbol: BIOVF
Market: OTC

Menu

BIOVF BIOVF Quote BIOVF Short BIOVF News BIOVF Articles BIOVF Message Board
Get BIOVF Alerts

News, Short Squeeze, Breakout and More Instantly...